YOSIPOVITCH, G. .; ZEIDLER, C. .; APFELBACHER, C. J. .; LAQUER, V. .; KIM, B. S. .; CASILLAS, M. .; PIERCE, E. .; CHEN, S. .; QIAO, M. .; AGELL, H. .; DEL ROSSO, J. . Lebrikizumab Delivers Clinically Meaningful and Continuous Improvement in Itch-Free Days in Atopic Dermatitis Through One Year. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 6, p. s273, 2023. DOI: 10.25251/skin.7.supp.273. Disponível em: https://jofskin.org/index.php/skin/article/view/2387. Acesso em: 3 jul. 2024.